WallStreetZenWallStreetZen

NASDAQ: CTXR
Citius Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CTXR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$39.3M
Current Profit Margin
0%

CTXR Return on Equity

Current Company
-43.2%
Current Industry
-63.5%
Current Market
188%
CTXR's Return on Equity (-43.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CTXR announces earnings.

CTXR Return on Assets

Current Company
-37.9%
Current Industry
2.9%
CTXR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CTXR Return on Capital Employed

Current Company
-40.95%
Current Industry
19.5%
CTXR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTXR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CTXR$0.00-$37.41M-$39.33MN/AN/A
RZLT$0.00-$56.28M-$56.83MN/AN/A
SEER$16.66M-$80.49M-$86.28M+246.19%N/A
BCAB$0.00-$122.24M-$123.46M-100.00%N/A
RNAC$26.00M-$233.28M-$219.71M+95.83%N/A
View Top Biotech Stocks

CTXR earnings dates

Next earnings date
May 10, 2024

Citius Pharmaceuticals Earnings & Revenue FAQ

What were CTXR's earnings last quarter?

On Invalid Date, Citius Pharmaceuticals (NASDAQ: CTXR) reported Q4 2023 earnings per share (EPS) of -$0.06, up 200% year over year. Total Citius Pharmaceuticals earnings for the quarter were -$9.23 million. In the same quarter last year, Citius Pharmaceuticals's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Citius Pharmaceuticals stock.

What was CTXR's earnings growth in the past year?

As of Q2 2024, Citius Pharmaceuticals's earnings has grown year over year. Citius Pharmaceuticals's earnings in the past year totalled -$39.33 million.

What is CTXR's earnings date?

Citius Pharmaceuticals's earnings date is Invalid Date. Add CTXR to your watchlist to be reminded of CTXR's next earnings announcement.

What was CTXR's revenue last quarter?

On Invalid Date, Citius Pharmaceuticals (NASDAQ: CTXR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Citius Pharmaceuticals's revenue was $0.00.

What was CTXR's revenue growth in the past year?

As of Q2 2024, Citius Pharmaceuticals's revenue has grown null year over year. Citius Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.